Amphastar Pharmaceuticals
AMPH
AMPH
246 hedge funds and large institutions have $1.8B invested in Amphastar Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 80 increasing their positions, 90 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more funds holding
Funds holding: 218 → 246 (+28)
2.01% more ownership
Funds ownership: 63.06% → 65.07% (+2%)
11% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 90
Holders
246
Holding in Top 10
2
Calls
$2.77M
Puts
$1.87M
Top Buyers
| 1 | +$60.9M | |
| 2 | +$26.9M | |
| 3 | +$14.8M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$10.3M |
| 5 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$8.71M |
Top Sellers
| 1 | -$27.5M | |
| 2 | -$13.6M | |
| 3 | -$11.3M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$9.33M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$9.1M |